
Tofen100 ml
Beximco Pharmaceuticals Ltd.
Ketotifen Fumarate is a second-generation antihistamine (H1-receptor antagonist) with additional mast cell-stabilizing activity.
Ketotifen Fumarate is a second-generation antihistamine (H1-receptor antagonist) with additional mast cell-stabilizing activity. Its established and commonly recognized uses include:
The prophylactic benefit of Ketotifen Fumarate in asthma may take several weeks of regular use to become fully established; any existing asthma medication should generally be continued during this period unless a physician advises otherwise.
| Population | Dose |
|---|---|
| Adults | 1 mg twice daily with food; may be increased to 2 mg twice daily in more severe cases if tolerated, under medical supervision. |
| Children (3 years and above) | 1 mg twice daily with food. |
| Children under 3 years | Use only on medical advice; safety and efficacy not well established for routine use. |
| Elderly | Same as adult dose; no specific dose reduction generally required. |
| Patients prone to sedation | An initial dose of 0.5-1 mg at night may be used before increasing to the standard twice-daily regimen. |
| Population | Dose |
|---|---|
| Adults and children 3 years and above | Instill one drop of Ketotifen Fumarate ophthalmic solution into the affected eye(s) twice daily, approximately 8-12 hours apart. Do not exceed two doses per day. |
| Children under 3 years | Consult a physician before use; safety and efficacy not established. |
If existing asthma therapy is being used, it should generally be continued for at least the first two weeks after starting oral Ketotifen Fumarate, as its full prophylactic effect develops gradually. Contact lenses should be removed before instilling the ophthalmic solution and may be reinserted after 10 minutes.
The most commonly reported side effects of Ketotifen Fumarate (oral) include:
These effects are usually mild and tend to resolve spontaneously with continued use. Weight gain has been reported with prolonged oral use in some patients. With the ophthalmic solution, transient stinging, burning, or eye irritation upon instillation may occur; persistent eye pain, redness, or vision changes should prompt discontinuation and medical evaluation.
Ketotifen Fumarate is contraindicated in patients with known hypersensitivity to ketotifen fumarate or to any excipient in the specific formulation being used.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.